GLUCURONIDATED ACETAMINOPHEN AS A MARKER OF HEPATIC DISORDERS
摘要
THE PRESENT INVENTION PROVIDES METHODS FOR DIAGNOSING HUMAN HEPATIC DISORDERS, IDENTIFYING A HUMAN SUBJECT AT RISK OF AN ADVERSE DRUG REACTION, AND DETERMINING AN APPROPRIATE DOSAGE OF A THERAPEUTIC DRUG FOR A HUMAN SUBJECT. (FIGURE 1)
申请公布号
MY156251(A)
申请公布日期
2016.01.29
申请号
MY2011PI01442
申请日期
2009.09.30
申请人
THE ARIZONA BOARD OF REGENTS, ON BEHALF OF THE UNIVERSITY OF ARIZONA
